Business and science: What you need to know about SynBio

Business and science: What you need to know a...

Suivant

Listen again: Power Players - Why are young Indians joining the Cockroach protests?

A chance to listen again as Will Bain and Rahul Tandon are joined by the BBC's India Business Correspondent Arunoday Mukherjee to look at the rise of the 'Cockroach movement'. They discuss the economic concerns of young people and the difficulties getting well paid jobsProducer: ...  Afficher plus

Headspace: from mindfulness app to military partner

Headspace started life as a mindfulness app. Now it's partnering with the US Navy and investing in artificial intelligence for mental health support.The company's CEO Tom Pickett speaks to us about therapy, the increasing role of technology, and tackling burnout at scale.If you'd ...  Afficher plus

Épisodes Recommandés

Turning Cells into Tiny Factories
What's Your Problem?

Reshma Shetty is co-founder and chief operations officer of Ginkgo Bioworks. Her problem: How do you turn cutting-edge science into a sustainable business?

Ginkgo is a synthetic biology company. The idea is to make industrial products -- fragrances, or food, or whatever ...

  Afficher plus

The Science Behind Building a Profitable Business
Shopify Masters

You'll learn the rules of thumb from building a successful business from a serial entrepreneur. 

For more on Beast and  show notes: https://www.shopify.com/blog/beast-inventory-management?utm_campaign=shopifymasters&utm_medium=description&utm_source=podcast

<h3 ...  Afficher plus

Business Plans and Science Projects
Motley Fool Hidden Gems Investing

Do you have a real relationship or just a non-binding letter of intent? (00:21) Nick Sciple and Mary Long discuss: - The S&P’s turnaround and inflation’s slow month-over-month decline. - A stock pop from a nuclear reactor company that doesn’t have a working nuclear reactor. - Pri ...  Afficher plus

Leading with science: A deep dive on biotech
Center For Investment Excellence

In this episode, David Lebovitz, Global Strategist, Multi-Asset Solutions, is joined by Stephen Squinto, Chief Investment Officer, J.P. Morgan Life Sciences Private Capital, to discuss the alternative investment landscape, the private biotech market and areas of opportunity in 20 ...  Afficher plus